Xolair (Omalizumab) is an asthma medication designed to treat allergy induced asthma. Xolair blocks your immune system’s response and reaction to generally benign common allergens which act as triggers, such as animal dander, food additives such as sulfites, mold, chemicals, drugs, dust mites, cockroaches, exhaust fumes, feathers, and tobacco smoke.
Xolair blocks allergy causing IgE antibodies produced by your immune system to attack substances which have entered your body. If you suffer from allergic asthma, Xolair may significantly reduce the number and severity of the asthma attacks (episodes) you will experience by blocking the action of your IgE antibodies.
Xolair asthma medication treatments involve injections every two to four weeks. Your doctor may recommend Xolair asthma treatments if you’re at least 12 years of age, if all other treatment options have been a failure and you suffer from allergy induced asthma with moderate to severe symptoms.
There are serious side effects and risks associated with Xolair. They may include possible blood-clotting problems, possible links to cancer which are currently being researched and the risk of severe reaction within two to three hours of taking the injection. As always, discuss your asthma treatment options, including Xolair, with your care providers and make an informed decision.